GulfHindi English Desk: Earum Pharmaceuticals witnessed a decrease in its share prices. On Friday, there was a 3.87% decline in the shares, bringing the share price to Rs 1.49 per share. In comparison to the previous closing, the stock’s lower level was Rs 1.48 and the higher level was Rs 1.62, as opposed to Rs 1.55. The highest and lowest prices for this share in the past 52 weeks were Rs 3.64 and Rs 1.45, respectively.
The sudden surge in share prices can be attributed to the company’s announcement of a director’s meeting on July 21, 2023. The meeting will discuss and deliberate on the following topics:
1. Proposal for the purchase of the company’s equity shares.
2. Announcement of the final dividend for FY 2022-23.
3. Proposal to issue bonus equity shares to existing equity shareholders of the company.
4. Proposal for the split of the company’s equity shares.
Earum Pharmaceuticals Limited is engaged in the manufacturing and distribution of pharmaceutical products. The company provides tablets, capsules, ointments, creams, gels, powders, and syrups. Earum Pharmaceuticals brings its products to the market on a global scale.
The market capitalization of Earum Pharmaceuticals is Rs 36.82 crore. The company has presented positive figures in both quarterly and annual results. The PE ratio of this share is 18.60x, while the industry PE ratio is 30x.
In summary, Earum Pharmaceuticals has experienced a decline in share prices, but the upcoming director’s meeting may have a significant impact on the company’s future prospects.
en.gulfhindi.com News Summary
👉Earum Pharmaceuticals’ shares experienced a decline of 3.87% on Friday, with the share price dropping to Rs 1.49 per share compared to the previous closing price of Rs 1.55.
👉The lowest level of the share price was Rs 1.48, while the highest level was Rs 1.62.
👉The 52-week highest price of the share was Rs 3.64, and the lowest price was Rs 1.45.
👉The sudden increase in share price is due to the company’s announcement of a board meeting on July 21, 2023, where discussions will be held on various topics, including the proposal to purchase equity shares, declaration of FY 2022-23 final dividend, issuance of bonus equity shares to existing shareholders, and the proposal for a share split.
👉Earum Pharmaceuticals is involved in the manufacturing and distribution of pharmaceutical products, including tablets, capsules, ointments, creams, gels, powders, and syrups. The company operates in the global market.
👉The market capitalization of Earum Pharmaceuticals is Rs 36.82 crore. The company has presented positive figures in both quarterly and annual results. The PE ratio of this share is 18.60x, while the industry PE ratio is 30x.
👉The board meeting is scheduled for July 21, 2023.
👉Related post: [Link to related post]
You are reading Mid-East Award Winning news outlet GulfHindi
